101 related articles for article (PubMed ID: 30295067)
1. Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate Cancer.
Guedes LB; Morais CL; Fedor H; Hicks J; Gurel B; Melamed J; Lee P; Gopalan A; Knudsen BS; True LD; Scher HI; Fine SW; Trock BJ; De Marzo AM; Lotan TL
Arch Pathol Lab Med; 2019 Mar; 143(3):338-348. PubMed ID: 30295067
[TBL] [Abstract][Full Text] [Related]
2. Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues.
Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X
Hum Pathol; 2014 Mar; 45(3):522-32. PubMed ID: 24457075
[TBL] [Abstract][Full Text] [Related]
3. Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH Analysis.
Sathyanarayana UG; Birch C; Nagle RB; Tomlins SA; Palanisamy N; Zhang W; Hubbard A; Brunhoeber P; Wang Y; Tang L
Appl Immunohistochem Mol Morphol; 2015; 23(5):364-73. PubMed ID: 25265431
[TBL] [Abstract][Full Text] [Related]
4. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
Jacobs TW; Prioleau JE; Stillman IE; Schnitt SJ
J Natl Cancer Inst; 1996 Aug; 88(15):1054-9. PubMed ID: 8683636
[TBL] [Abstract][Full Text] [Related]
5. A robust immunohistochemical assay for detecting PTEN expression in human tumors.
Sangale Z; Prass C; Carlson A; Tikishvili E; Degrado J; Lanchbury J; Stone S
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):173-83. PubMed ID: 20930614
[TBL] [Abstract][Full Text] [Related]
6. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.
Morais CL; Han JS; Gordetsky J; Nagar MS; Anderson AE; Lee S; Hicks JL; Zhou M; Magi-Galluzzi C; Shah RB; Epstein JI; De Marzo AM; Lotan TL
Am J Surg Pathol; 2015 Feb; 39(2):169-78. PubMed ID: 25517949
[TBL] [Abstract][Full Text] [Related]
7. ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.
Morais CL; Guedes LB; Hicks J; Baras AS; De Marzo AM; Lotan TL
Hum Pathol; 2016 Sep; 55():117-25. PubMed ID: 27189342
[TBL] [Abstract][Full Text] [Related]
8. In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading.
Picanço-Albuquerque CG; Morais CL; Carvalho FL; Peskoe SB; Hicks JL; Ludkovski O; Vidotto T; Fedor H; Humphreys E; Han M; Platz EA; De Marzo AM; Berman DM; Lotan TL; Squire JA
Virchows Arch; 2016 May; 468(5):607-17. PubMed ID: 26861919
[TBL] [Abstract][Full Text] [Related]
9. Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.
Lotan TL; Wei W; Ludkovski O; Morais CL; Guedes LB; Jamaspishvili T; Lopez K; Hawley ST; Feng Z; Fazli L; Hurtado-Coll A; McKenney JK; Simko J; Carroll PR; Gleave M; Lin DW; Nelson PS; Thompson IM; True LD; Brooks JD; Lance R; Troyer D; Squire JA
Mod Pathol; 2016 Aug; 29(8):904-14. PubMed ID: 27174589
[TBL] [Abstract][Full Text] [Related]
10. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
Leapman MS; Nguyen HG; Cowan JE; Xue L; Stohr B; Simko J; Cooperberg MR; Carroll PR
Eur Urol; 2018 Nov; 74(5):668-675. PubMed ID: 30181067
[TBL] [Abstract][Full Text] [Related]
11. The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN Status.
Magi-Galluzzi C; Isharwal S; Falzarano SM; Tsiatis A; Dee A; Maddala T; Knezevic D; Febbo PG; Lawrence J; Klein EA
Urology; 2018 Nov; 121():132-138. PubMed ID: 30142405
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
Ahearn TU; Pettersson A; Ebot EM; Gerke T; Graff RE; Morais CL; Hicks JL; Wilson KM; Rider JR; Sesso HD; Fiorentino M; Flavin R; Finn S; Giovannucci EL; Loda M; Stampfer MJ; De Marzo AM; Mucci LA; Lotan TL
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26615022
[TBL] [Abstract][Full Text] [Related]
13. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform.
Ronen S; Abbott DW; Kravtsov O; Abdelkader A; Xu Y; Banerjee A; Iczkowski KA
Hum Pathol; 2017 Jul; 65():85-91. PubMed ID: 28504208
[TBL] [Abstract][Full Text] [Related]
14. PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.
Lotan TL; Gurel B; Sutcliffe S; Esopi D; Liu W; Xu J; Hicks JL; Park BH; Humphreys E; Partin AW; Han M; Netto GJ; Isaacs WB; De Marzo AM
Clin Cancer Res; 2011 Oct; 17(20):6563-73. PubMed ID: 21878536
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling.
Shah RB; Bentley J; Jeffery Z; DeMarzo AM
Hum Pathol; 2015 May; 46(5):698-706. PubMed ID: 25724568
[TBL] [Abstract][Full Text] [Related]
16. High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts.
Harmon SA; Patel PG; Sanford TH; Caven I; Iseman R; Vidotto T; Picanço C; Squire JA; Masoudi S; Mehralivand S; Choyke PL; Berman DM; Turkbey B; Jamaspishvili T
Mod Pathol; 2021 Feb; 34(2):478-489. PubMed ID: 32884130
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of ERG and PTEN protein expression in cribriform architecture prostate carcinomas.
Downes MR; Satturwar S; Trudel D; van der Kwast TH
Pathol Res Pract; 2017 Jan; 213(1):34-38. PubMed ID: 27913052
[TBL] [Abstract][Full Text] [Related]
18. PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer.
Mithal P; Allott E; Gerber L; Reid J; Welbourn W; Tikishvili E; Park J; Younus A; Sangale Z; Lanchbury JS; Stone S; Freedland SJ
Int J Urol; 2014 Dec; 21(12):1209-14. PubMed ID: 25099119
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies.
Vanguri VK; Woda BA; Jiang Z
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):365-8. PubMed ID: 16932031
[TBL] [Abstract][Full Text] [Related]
20. PTEN Loss in Gleason Score 3 + 4 = 7 Prostate Biopsies is Associated with Nonorgan Confined Disease at Radical Prostatectomy.
Guedes LB; Tosoian JJ; Hicks J; Ross AE; Lotan TL
J Urol; 2017 Apr; 197(4):1054-1059. PubMed ID: 27693448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
